LGHT Langar Global HealthTech ETF

ETF on NYSE (US) · Actively managed · Listing

Form N-PORT Jun 30, 2026 vs Mar 31, 2026 Filed with the SEC Aug 28, 2026
Book −18% $3.03M → $2.47M
Line items (Mar 31, 2026: 31) 29
In top 10 73%
Largest holding: UMB MONEY MARKET ($416K) 16.8%
Portfolio date Jun 30, 2026
New / increased 0 / 7
Reduced / closed 21 / 2
Unchanged 0
−37%

Most notable sale · Intuitive Surgical, Inc.

Intuitive Surgical, Inc. cut by 37%

Shares went from 985 to 617 ($454K → $245K). Now 9.9% of the portfolio. Estimated trade $146K.

+29%

Most notable buy · Moderna, Inc.

Moderna, Inc. raised by 29%

Shares went from 2,177 to 2,819 ($111K → $197K). Now 8.0% of the portfolio. Estimated trade $45.0K.

Largest holding: UMB MONEY MARKET, raised 5.6x, 416,342 units ($416K).

UMB MONEY MARKET: 16.8% Intuitive Surgical, Inc.: 9.9% ResMed Inc.: 9.1% Moderna, Inc.: 8.0% Veeva Systems Inc.: 5.6% GE HealthCare Technologies Inc.: 5.4% IQVIA Holdings, Inc.: 5.0% Koninklijke Philips N.V. NY Registry Shares: 4.6% Insulet Corporation: 4.4% DexCom, Inc.: 4.0% The other 19 positions: 27.1% $2.47M Holdings value
Current positions Top 10 % of book
UMB MONEY MARKET AMBXX $416K · 5.6x units 16.8%
Intuitive Surgical, Inc. ISRG $245K · −37% sh 9.9%
ResMed Inc. RMD $225K · −15% sh 9.1%
Moderna, Inc. MRNA $197K · +29% sh 8.0%
Veeva Systems Inc. VEEV $138K · −29% sh 5.6%
GE HealthCare Technologies Inc. GEHC $134K · −45% sh 5.4%
IQVIA Holdings, Inc. IQV $123K · −31% sh 5.0%
Koninklijke Philips N.V. NY Registry Shares PHG $114K · −29% sh 4.6%
Insulet Corporation PODD $110K · −13% sh 4.4%
DexCom, Inc. DXCM $99.2K · −31% sh 4.0%

Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Mar 31, 2026.

Healthcare: 70.1% Technology: 5.6% Communication Services: 1.6% Unclassified: 22.7% 3 sectors
Sectors % of holdings value
Healthcare 70.1%
Technology 5.6%
Communication Services 1.6%
Unclassified 22.7%
Medical Devices: 47.7% Biotechnology: 12.5% Software - Application: 5.6% Health Information Services: 5.1% Healthcare Plans: 4.5% Internet Content & Information: 1.6% Medical Care Facilities: 0.3% Unclassified: 22.7% 7 industries
Industries % of holdings value
Medical Devices 47.7%
Biotechnology 12.5%
Software - Application 5.6%
Health Information Services 5.1%
Healthcare Plans 4.5%
Internet Content & Information 1.6%
Medical Care Facilities 0.3%
Unclassified 22.7%
Initiations 0 Value
None this period.
Increases 7 Change
Moderna, Inc. MRNA $111K → $197K +29%
iRhythm Holdings, Inc. IRTC $33.9K → $59.1K +73%
Alignment Healthcare, Inc. ALHC $16.5K → $46.4K 2.1x
Doximity, Inc. DOCS $38.5K → $40.1K +17%
Privia Health Group, Inc. PRVA $30.4K → $40.3K +6%
PROCEPT BioRobotics Corporation PRCT $14.2K → $14.5K +13%
Phreesia, Inc. PHR $2.88K → $3.65K +3%
Reductions 21 Change
Intuitive Surgical, Inc. ISRG $454K → $245K −37%
GE HealthCare Technologies Inc. GEHC $272K → $134K −45%
Siemens Healthineers $155K → $78.8K −45%
Veeva Systems Inc. VEEV $194K → $138K −29%
IQVIA Holdings, Inc. IQV $158K → $123K −31%
Zimmer Biomet Holdings, Inc. ZBH $151K → $92.8K −36%
BioNTech SE BNTX $114K → $71.4K −40%
Koninklijke Philips N.V. NY Registry Shares PHG $163K → $114K −29%
DexCom, Inc. DXCM $134K → $99.2K −31%
Sonova Holding AG $104K → $64.6K −40%
ResMed Inc. RMD $307K → $225K −15%
Alkermes plc ALKS $41.5K → $35.1K −43%
Terminations 2 Change
Masimo Corp was $86.1K −100%
Cochlear Ltd was $55.6K −100%

The other 9 reductions

Align Technology, Inc. (−24%), Insulet Corporation (−13%), Omnicell, Inc. (−28%), Teladoc Health, Inc. (−31%), LifeStance Health Group, Inc. (−27%), Progyny, Inc. (−12%), Schrodinger, Inc. (−25%), Tandem Diabetes Care, Inc. (−9%), TRUEBRIDGE INC (−20%)

Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jun 30, 2026 (Form N-PORT) vs the portfolio of Mar 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.

Objective

Langar Global HealthTech ETF (the "Fund") seeks long-term growth of capital.

Principal investment strategies

As an actively managed exchange-traded fund ("ETF"), the Fund will not seek to replicate the performance of an index. The Fund intends to achieve its investment objective by investing a majority of its net assets in U.S. and foreign exchange-listed healthcare technology companies in the U.S. and a number of developed countries around the world. Under normal circumstances, the Fund will invest at least 80% of the Fund's net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts ("ADRs") on those securities. These securities may be of any market capitalization. 2 Langar Investment Management, LLC (the "Advisor") uses a combination of a top-down review and a bottom-up research methodology to select fundamentally strong companies that develop technology to create efficiency in healthcare by addressing key pain points for patients, providers, payors, and/or hospitals. The Advisor defines pain points as consistent problems that a patient, provider and/or other healthcare stakeholder has when dealing with a product and/or service, which are unmet needs that are not adequately addressed for a company to solve in the market. These companies are generally in one of the nine subsectors described below and may include robotic surgery companies, virtual and/or telemedicine companies, companies that develop next-generation insurance payment models, drug development companies leveraging artificial intelligence (AI), digital clinical trial companies, companies that address operational issues within a hospital, and companies that leverage large language model (LLM) AI to develop next best recommendation engines to improve/facilitate the intake, monitoring, and treatment of a patient. The Advisor's selection process has four main steps (as further described below): 1) Langar's HealthTech classification; 2) Langar Rating™; 3) Langar's HealthTech Industry Risk Score; and 4) Investment Committee review. Langar's HealthTech Classification The Advisor starts by recategorizing public companies in the healthcare industry as defined by the Standard & Poor's Global Industry Classification Standard ("GICS") to determine the companies that fit into the Advisor's definition of a HealthTech company. The Advisor defines a "HealthTech Company" as a company that: i) develops technology to create efficiencies in healthcare by addressing key pain points of patients, providers, payors and/or hospitals; and ii) receives a majority of its revenue from HealthTech products and/or services as reported through filings with the SEC. HealthTech companies can be grouped into nine subsectors: Public HealthTech subsector definitions: • Access to Care – Provide care outside of a hospital setting through virtual, in-person, or a hybrid care combination. • Biopharma – Pharmaceutical and biotechnology companies that use artificial intelligence/machine learning ("AI/ML") technologies as an integral part of their drug design or development process. • Clinical Trials – Enables the efficient deployment, tracking and/or completion of trials that support novel medications and/or treatments. • Decision Support – Provides clinicians with patient-specific information, which is intelligently filtered or presented at appropriate times to enhance care. • Hospital Operations – Improves the efficiency of hospital workflows that are required to provide care. • Insurance – Leverage AI/ML models to save costs and improve services of private and/or government programs. • Treatment Device – Devices that leverage an AI/ML algorithm to facilitate treatment of a specific medical problem. Private HealthTech subsector definitions: • Lifestyle Wellness – Assists users in navigating their overall health and wellness journey using monitoring, counseling, education, and lifestyle changes that help prevent, treat, and provide care.

Management and Contact

Adviser
Langar Investment Management, LLC
Portfolio managers

Dhruv K. Vig, Ph.

D., is the portfolio manager of the Fund and is primarily responsible for the day-to-day management of the Fund's portfolio.

Dr. Vig has served as the Fund's portfolio manager since its inception in January 2024.

Phone
1-800-773-3863

Track Record as of Dec 31, 2025

1 Year Since Inception
S&P 500 Health Care Index (reflects no deductions for fees and expenses) 14.60% 6.91%
S&P 500 Index (reflects no deductions for fees and expenses) 17.88% 21.81%

Holdings as of Jun 30, 2026

29 lines, 25 linked, weights sum to 100.02% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
UMB MONEY MARKET
AMBXX Money market 416,341.6 +342,331.4 16.83% $ 416.342K
Intuitive Surgical I US46120E6023 Equity 617 −368 9.92% $ 245.369K
ResMed Inc US7611521078 Equity 1,156 −210 9.11% $ 225.281K
Moderna Inc US60770K1079 Equity 2,819 +642 7.98% $ 197.415K
Veeva Systems Inc US9224751084 Equity 780 −322 5.60% $ 138.427K
GE HealthCare US36266G1076 Equity 2,091 −1,734 5.41% $ 133.845K
IQVIA Holdings Inc US46266C1053 Equity 638 −287 4.98% $ 123.274K
Koninklijke Philips US5004723038 Equity 4,202 −1,755 4.62% $ 114.252K
Insulet Corp US45784P1012 Equity 721 −109 4.44% $ 109.772K
DEXCOM INC COM US2521311074 Equity 1,473 −668 4.01% $ 99.207K
Zimmer Biomet Holdin US98956P1021 Equity 1,078 −594 3.75% $ 92.805K
Siemens Healthineers
US82622J1043 Equity 4,048 −3,268 3.19% $ 78.815K
BioNTech SE US09075V1026 Equity 767 −515 2.88% $ 71.369K
Align Technology Inc US0162551016 Equity 399 −125 2.72% $ 67.295K
Sonova Holding AG
US83569C1027 Equity 1,365 −925 2.61% $ 64.578K
iRhythm Holdings US4500561067 Equity 497 +210 2.39% $ 59.118K
Alignment Healthcare US01625V1044 Equity 1,950 +1,011 1.88% $ 46.43K
Privia Health Group US74276R1023 Equity 1,568 +88 1.63% $ 40.345K
Doximity Inc US26622P1075 Equity 1,934 +281 1.62% $ 40.111K
Alkermes PLC IE00B56GVS15 Equity 670 −505 1.42% $ 35.105K
Progyny Inc US74340E1038 Equity 551 −74 0.64% $ 15.885K
PROCEPT BioRobotics US74276L1052 Equity 641 +73 0.59% $ 14.474K
Omnicell Inc US68213N1090 Equity 271 −105 0.45% $ 11.252K
Teladoc Inc US87918A1051 Equity 1,052 −467 0.36% $ 8,920.96
LifeStance Health Gr US53228F1012 Equity 645 −237 0.28% $ 6,907.95
Tandem Diabetes Care US8753722037 Equity 437 −42 0.27% $ 6,594.33
SCHRODINGER INC US80810D1037 Equity 382 −127 0.25% $ 6,207.50
PHREESIA INC US71944F1066 Equity 355 +11 0.15% $ 3,652.95
TRUEBRIDGE INC
US2053061030 Equity 40 −10 0.04% $ 1,048.40

Trades Mar 31, 2026 to Jun 30, 2026

Holding Ticker Action Before After Change Value
Intuitive Surgical I Sold 985 617 −368 $ -146.346K
GE HealthCare Sold 3,825 2,091 −1,734 $ -110.993K
Masimo Corp
Closed 484 — −484 $ -86.089K
Siemens Healthineers
Sold 7,316 4,048 −3,268 $ -63.628K
Veeva Systems Inc Sold 1,102 780 −322 $ -57.145K
Cochlear Ltd
Closed 943 — −943 $ -55.637K
IQVIA Holdings Inc Sold 925 638 −287 $ -55.454K
Zimmer Biomet Holdin Sold 1,672 1,078 −594 $ -51.137K
BioNTech SE Sold 1,282 767 −515 $ -47.921K
Koninklijke Philips Sold 5,957 4,202 −1,755 $ -47.718K
DEXCOM INC COM Sold 2,141 1,473 −668 $ -44.99K
Moderna Inc Bought 2,177 2,819 +642 $ 44.959K
Sonova Holding AG
Sold 2,290 1,365 −925 $ -43.762K
ResMed Inc Sold 1,366 1,156 −210 $ -40.925K
Alkermes PLC Sold 1,175 670 −505 $ -26.459K
iRhythm Holdings Bought 287 497 +210 $ 24.98K
Alignment Healthcare Bought 939 1,950 +1,011 $ 24.072K
Align Technology Inc Sold 524 399 −125 $ -21.083K
Insulet Corp Sold 830 721 −109 $ -16.595K
Doximity Inc Bought 1,653 1,934 +281 $ 5,827.94
Omnicell Inc Sold 376 271 −105 $ -4,359.60
Teladoc Inc Sold 1,519 1,052 −467 $ -3,960.16
LifeStance Health Gr Sold 882 645 −237 $ -2,538.27
Privia Health Group Bought 1,480 1,568 +88 $ 2,264.24
Progyny Inc Sold 625 551 −74 $ -2,133.42
SCHRODINGER INC Sold 509 382 −127 $ -2,063.75
PROCEPT BioRobotics Bought 568 641 +73 $ 1,648.34
Tandem Diabetes Care Sold 479 437 −42 $ -633.78
TRUEBRIDGE INC
Sold 50 40 −10 $ -262.10
PHREESIA INC Bought 344 355 +11 $ 113.19

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up